TIDMGSK

RNS Number : 6233L

GlaxoSmithKline PLC

13 September 2021

   GlaxoSmithKline plc   (the ' Company ') 

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =============================================================================== 
 a)   Name                         Ms E Walmsley 
===  ============================  ================================================= 
 b)   Position/status              Chief Executive Officer 
===  ============================  ================================================= 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =============================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ================================================= 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ================================================= 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan 
===  ============================  ================================================= 
 c)   Price(s) and                   Price(s)        Volume(s) 
       volume(s) 
===  ============================    ==============  ============================= 
                                     GBP14.3930      9 (partnership shares) 
===  ============================    ==============  ============================= 
                                     GBP14.3930      9 (matching shares) 
                                     ==============  ============================= 
 
 d)   Aggregated information 
=== 
      Aggregated volume            18 Ordinary Shares 
       Price                        GBP14.3930 
===  ============================  ================================================= 
 e)   Date of the transaction      2021-09-09 
===  ============================  ================================================= 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =============================================================================== 
 a)   Name                         Mr R Connor 
===  ============================  ================================================= 
 b)   Position/status              President, Vaccines & Global Health 
===  ============================  ================================================= 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =============================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ================================================= 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ================================================= 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan 
===  ============================  ================================================= 
 c)   Price(s) and                   Price(s)        Volume(s) 
       volume(s) 
===  ============================    ==============  ============================= 
                                     GBP14.3930      9 (partnership shares) 
===  ============================    ==============  ============================= 
                                     GBP14.3930      9 (matching shares) 
                                     ==============  ============================= 
 
 d)   Aggregated information 
=== 
      Aggregated volume            18 Ordinary Shares 
       Price                        GBP14.3930 
===  ============================  ================================================= 
 e)   Date of the transaction      2021-09-09 
===  ============================  ================================================= 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =============================================================================== 
 a)   Name                         Ms D Conrad 
===  ============================  ================================================= 
 b)   Position/status              SVP, Human Resources 
===  ============================  ================================================= 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =============================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ================================================= 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ================================================= 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan 
===  ============================  ================================================= 
 c)   Price(s) and                   Price(s)        Volume(s) 
       volume(s) 
===  ============================    ==============  ============================= 
                                     GBP14.3930      9 (partnership shares) 
===  ============================    ==============  ============================= 
                                     GBP14.3930      9 (matching shares) 
                                     ==============  ============================= 
 
 d)   Aggregated information 
=== 
      Aggregated volume            18 Ordinary Shares 
       Price                        GBP14.3930 
===  ============================  ================================================= 
 e)   Date of the transaction      2021-09-09 
===  ============================  ================================================= 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =============================================================================== 
 a)   Name                         Mr J Ford 
===  ============================  ================================================= 
 b)   Position/status              SVP and General Counsel 
===  ============================  ================================================= 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =============================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ================================================= 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ================================================= 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan 
===  ============================  ================================================= 
 c)   Price(s) and                   Price(s)        Volume(s) 
       volume(s) 
===  ============================    ==============  ============================= 
                                     GBP14.3930      9 (partnership shares) 
===  ============================    ==============  ============================= 
                                     GBP14.3930      9 (matching shares) 
                                     ==============  ============================= 
 
 d)   Aggregated information 
=== 
      Aggregated volume            18 Ordinary Shares 
       Price                        GBP14.3930 
===  ============================  ================================================= 
 e)   Date of the transaction      2021-09-09 
===  ============================  ================================================= 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =============================================================================== 
 a)   Name                         Ms S Jackson 
===  ============================  ================================================= 
 b)   Position/status              SVP, Global Communications and CEO Office 
===  ============================  ================================================= 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =============================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ================================================= 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ================================================= 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan 
===  ============================  ================================================= 
 c)   Price(s) and                   Price(s)        Volume(s) 
       volume(s) 
===  ============================    ==============  ============================= 
                                     GBP14.3930      9 (partnership shares) 
===  ============================    ==============  ============================= 
                                     GBP14.3930      9 (matching shares) 
                                     ==============  ============================= 
 
 d)   Aggregated information 
=== 
      Aggregated volume            18 Ordinary Shares 
       Price                        GBP14.3930 
===  ============================  ================================================= 
 e)   Date of the transaction      2021-09-09 
===  ============================  ================================================= 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =================================================================================== 
 a)   Name                         Mr D Jackson 
===  ============================  ===================================================== 
 b)   Position/status              PCA of Ms S Jackson (SVP, Global Communications 
                                    and CEO Office) 
===  ============================  ===================================================== 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ===================================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =================================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ===================================================== 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ===================================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =================================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ===================================================== 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan 
===  ============================  ===================================================== 
 c)   Price(s) and                   Price(s)          Volume(s) 
       volume(s) 
===  ============================    ================  =============================== 
                                     GBP14.3930        9 (partnership shares) 
===  ============================    ================  =============================== 
                                     GBP14.3930        9 (matching shares) 
                                     ================  =============================== 
 
 d)   Aggregated information 
=== 
      Aggregated volume            18 Ordinary Shares 
       Price                        GBP14.3930 
===  ============================  ===================================================== 
 e)   Date of the transaction      2021-09-09 
===  ============================  ===================================================== 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ===================================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =============================================================================== 
 a)   Name                         Mr D Redfern 
===  ============================  ================================================= 
 b)   Position/status              Chief Strategy Officer 
===  ============================  ================================================= 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =============================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ================================================= 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ================================================= 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan 
===  ============================  ================================================= 
 c)   Price(s) and                   Price(s)        Volume(s) 
       volume(s) 
===  ============================    ==============  ============================= 
                                     GBP 14.3930     9 (partnership shares) 
===  ============================    ==============  ============================= 
                                     GBP 14.3930     9 (matching shares) 
                                     ==============  ============================= 
 
 d)   Aggregated information 
=== 
      Aggregated volume            18 Ordinary Shares 
       Price                        GBP 14.3930 
===  ============================  ================================================= 
 e)   Date of the transaction      2021-09-09 
===  ============================  ================================================= 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =============================================================================== 
 a)   Name                         Mr R Simard 
===  ============================  ================================================= 
 b)   Position/status              President, Pharmaceuticals Supply Chain 
===  ============================  ================================================= 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =============================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ================================================= 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ================================================= 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan 
===  ============================  ================================================= 
 c)   Price(s) and                   Price(s)        Volume(s) 
       volume(s) 
===  ============================    ==============  ============================= 
                                     GBP 14.3930     8 (partnership shares) 
===  ============================    ==============  ============================= 
                                     GBP 14.3930     8 (matching shares) 
                                     ==============  ============================= 
 
 d)   Aggregated information 
=== 
      Aggregated volume            16 Ordinary Shares 
       Price                        GBP 14.3930 
===  ============================  ================================================= 
 e)   Date of the transaction      2021-09-09 
===  ============================  ================================================= 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =============================================================================== 
 a)   Name                         Mr P Thomson 
===  ============================  ================================================= 
 b)   Position/status              President, Global Affairs 
===  ============================  ================================================= 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =============================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ================================================= 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ================================================= 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan 
===  ============================  ================================================= 
 c)   Price(s) and                   Price(s)        Volume(s) 
       volume(s) 
===  ============================    ==============  ============================= 
                                     GBP 14.3930     9 (partnership shares) 
===  ============================    ==============  ============================= 
                                     GBP 14.3930     9 (matching shares) 
                                     ==============  ============================= 
 
 d)   Aggregated information 
=== 
      Aggregated volume            18 Ordinary Shares 
       Price                        GBP 14.3930 
===  ============================  ================================================= 
 e)   Date of the transaction      2021-09-09 
===  ============================  ================================================= 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =============================================================================== 
 a)   Name                         Ms D Waterhouse 
===  ============================  ================================================= 
 b)   Position/status              Chief Executive Officer of ViiV Healthcare 
===  ============================  ================================================= 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =============================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ================================================= 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ================================================= 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan 
===  ============================  ================================================= 
 c)   Price(s) and                   Price(s)        Volume(s) 
       volume(s) 
===  ============================    ==============  ============================= 
                                     GBP14.3930      9 (partnership shares) 
===  ============================    ==============  ============================= 
                                     GBP14.3930      9 (matching shares) 
                                     ==============  ============================= 
 
 d)   Aggregated information 
=== 
      Aggregated volume            18 Ordinary Shares 
       Price                        GBP14.3930 
===  ============================  ================================================= 
 e)   Date of the transaction      2021-09-09 
===  ============================  ================================================= 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =============================================================================== 
 a)   Name                         Ms V Whyte 
===  ============================  ================================================= 
 b)   Position/status              Company Secretary 
===  ============================  ================================================= 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =============================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ================================================= 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ================================================= 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan 
===  ============================  ================================================= 
 c)   Price(s) and                   Price(s)        Volume(s) 
       volume(s) 
===  ============================    ==============  ============================= 
                                     GBP 14.3930     9 (partnership shares) 
===  ============================    ==============  ============================= 
                                     GBP 14.3930     9 (matching shares) 
                                     ==============  ============================= 
 
 d)   Aggregated information 
=== 
      Aggregated volume            18 Ordinary Shares 
       Price                        GBP 14.3930 
===  ============================  ================================================= 
 e)   Date of the transaction      2021-09-09 
===  ============================  ================================================= 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ================================================= 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHQXLFFFKLLBBZ

(END) Dow Jones Newswires

September 13, 2021 12:26 ET (16:26 GMT)

Grafico Azioni Glaxosmithkline (LSE:GSK)
Storico
Da Set 2021 a Ott 2021 Clicca qui per i Grafici di Glaxosmithkline
Grafico Azioni Glaxosmithkline (LSE:GSK)
Storico
Da Ott 2020 a Ott 2021 Clicca qui per i Grafici di Glaxosmithkline